The Saba Board of Directors shares its expertise and experience with the management team as Saba strives to attain our vision of making continuous, personalized learning a reality for business professionals in every extended enterprise around the world.

Bobby Yazdani
Bobby Yazdani is Chairman of the Board and CEO.

Joe Kiani
Joe Kiani has been a Director of Saba since July 1997. Mr. Kiani is the Founder of Masimo Corporation, a provider of signal processing and sensor technology to the medical device industry, and has served as its Chief Executive Officer and Chairman of the Board since Masimo's inception in 1989. Mr. Kiani holds a B.S. and M.S. from San Diego State University. Mr. Kiani serves on the Board of Director's Compensation and Corporate Governance and Nominating Committees.

Lawrence D. Lenihan, Jr.
Lawrence D. Lenihan, Jr. has been a Director of Saba since August 2004. Mr. Lenihan is a managing general partner and co-head of the Pequot venture funds and the Pequot private equity funds, funds which Mr. Lenihan joined in 1996. Previously, Mr. Lenihan was a principal with Broadview Associates, L.L.C., an investment banking firm, where he was a senior member of the mergers and acquisitions team. Prior to joining Broadview, Mr. Lenihan held various positions within IBM, an information technology, business and technology services, consulting services and information technology research company. Mr. Lenihan is also a Director of First Advantage Corporation, a risk mitigation and business solutions provider. Mr. Lenihan holds a B.S. from Duke University and a M.B.A. from the Wharton School of Business at the University of Pennsylvania. Mr. Lenihan serves on the Board of Director's Audit, Compensation and Corporate Governance and Nominating Committees.

George de Urioste
George de Urioste has joined the company's board of directors and serves as Chairman of the Audit Committee. Mr. de Urioste recently was the COO and CFO of Chordiant Software, a provider of enterprise software for customer service and marketing processes. Previously he had been the Chairman and CEO of Aeroprise, Inc., a private mobile workflow management software company that he co-founded in 2000. Prior to Aeroprise, Mr. de Urioste was the CFO and VP of Finance and Operations for Remedy Corporation, a provider of enterprise software. In his six-year tenure at Remedy, he was a member of the executive team that grew revenues from $2 million to a $200 million run rate. Mr. de Urioste began his career in 1980 as a CPA for Deloitte & Touche. He holds a B.S. in Accounting from the University of Southern California, and an M.B.A. in finance and international business from the University of California at Berkeley.

Dow R. Wilson
Dow R. Wilson has been a Director of Saba since August 2006. Mr. Wilson is Executive Vice President of Varian Medical Systems, a company that designs and manufactures advanced equipment and software products for treating cancer with radiation, and President of its Oncology Systems division. Mr. Wilson joined Varian in 2005, following a 19-year career with General Electric, a diversified industrial corporation, in a variety of senior management positions in both the United States and Europe. Most recently, Mr. Wilson served as CEO for GE Healthcare-Information and Patient Monitoring Technologies. Prior to that, he served as Global General Manager for a number of GE's imaging businesses, including, X-ray, Functional Imaging and Computed Tomography. He also ran GE's Lexan Sheet business in Europe. Mr. Wilson holds a B.A. from Brigham Young University and an M.B.A. from the Amos Tuck School of Business at Dartmouth College.